Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |